GoodEXOCells

GoodEXOCells is a South Korean biotechnology company focused on developing innovative exosome-based therapeutics for inflammatory and regenerative diseases. The company leverages its proprietary Exo-PLUS platform for the high-purity isolation of exosomes and its Exo-Target technology for precise surface engineering to enhance drug delivery. Their current pipeline includes programs for atopic dermatitis, alopecia, and inflammatory bowel disease, all utilizing mesenchymal stem cell-derived exosomes. By providing cell-free therapeutic solutions, GoodEXOCells aims to offer safer and more scalable alternatives to traditional stem cell therapies. The company is currently in the pre-clinical stage, advancing its lead candidates toward clinical trials.